Bank Of America Corp In8 Bio, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in In8 Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 266 shares of INAB stock, worth $82. This represents 0.0% of its overall portfolio holdings.
Number of Shares
266Holding current value
$82% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding INAB
# of Institutions
27Shares Held
7.74MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.13MShares$659,6790.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$441,4080.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$346,6620.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL641KShares$198,7120.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI600KShares$185,9000.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $7.6M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...